Proposed Data Collections Submitted for Public Comment and Recommendations, 40889-40890 [2012-16911]
Download as PDF
Federal Register / Vol. 77, No. 133 / Wednesday, July 11, 2012 / Notices
Kimberly S. Lane,
Deputy Director, Office of Science Integrity,
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2012–16912 Filed 7–10–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–12–12PE]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 and
send comments to Kimberly S. Lane, at
CDC 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an email to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
srobinson on DSK4SPTVN1PROD with NOTICES
Interventions to Reduce Shoulder
MSDs in Overhead Assembly—New
-National Institute for Occupational
Safety and Health (NIOSH), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The mission of the National Institute
for Occupational Safety and Health
(NIOSH) is to promote safety and health
at work for all people through research
and prevention. Under Public Law 91–
596, sections 20 and 22 (Section 20–22,
VerDate Mar<15>2010
18:11 Jul 10, 2012
Jkt 226001
Occupational Safety and Health Act of
1970), NIOSH has the responsibility to
conduct research to advance the health
and safety of workers. In this capacity,
NIOSH proposes to conduct a study to
assess the effectiveness and cost-benefit
of occupational safety and health (OSH)
interventions to prevent
musculoskeletal disorders (MSDs)
among workers in the Manufacturing
(MNF) sector.
Musculoskeletal disorders (MSDs)
represent a major proportion of injury/
illness incidence and cost in the U.S.
Manufacturing (MNF) sector. In 2008,
29% of non-fatal injuries and illnesses
involving days away from work (DAW)
in the MNF sector involved MSDs and
the MNF sector had some of the highest
rates of MSD DAW cases. The rate for
the motor vehicle manufacturing subsector (NAICS 3361) was among the
highest of MNF sub sectors, with MSD
DAW rates that were higher than the
general manufacturing MSD DAW rates
from 2003–2007. In automotive
manufacturing, overhead conveyance of
the vehicle chassis requires assembly
line employees to use tools in working
postures with the arms elevated. These
postures are believed to be associated
with symptoms of upper limb
discomfort, fatigue, and impingement
syndromes (Fischer et al., 2007).
Overhead working posture, independent
of the force or load exerted with the
hands, may play a role in the
development in these conditions.
However, recent studies suggest a more
significant role of localized shoulder
muscle fatigue in contributing to these
disorders. Fatigue of the shoulder
muscles may result in changes in
normal shoulder kinematics (motion)
that affect risk for shoulder
impingement disorders (Ebaugh et. al.,
2006; Chopp et al., 2010).
The U.S. Manufacturing sector has
faced a number of challenges including
an overall decline in jobs, an aging
workforce, and changes in
organizational management systems.
Studies have indicated that the average
age of industrial workers is increasing
and that older workers may differ from
younger workers in work capacity,
injury risk, severity of injuries, and
speed of recovery (Kenny et al., 2008;
Gall et al., 2004; Restrepo et al., 2006).
As the average age of the industrial
population increases and newer systems
of work organization (such as lean
manufacturing) are changing the nature
of labor-intensive work, prevention of
MSDs will be more critical to protecting
older workers and maintaining
productivity.
This study will evaluate the efficacy
of two intervention strategies for
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
40889
reducing musculoskeletal symptoms
and pain in the shoulder attributable to
overhead assembly work in automotive
manufacturing. These interventions are,
(1) an articulating spring-tensioned tool
support device that unloads from the
worker the weight of the tool that would
otherwise be manually supported, and,
(2) a targeted exercise program intended
to increase individual employees’
strength and endurance in the shoulder
and upper arm stabilizing muscle group.
As a primary prevention strategy, the
tool support engineering control
approach is preferred; however, a costefficient opportunity exists to
concurrently evaluate the efficacy of a
preventive exercise program
intervention. Both of these intervention
approaches have been used in the
Manufacturing sector, and preliminary
evidence suggests that both approaches
may have merit. However, high quality
evidence demonstrating their
effectiveness, by way of controlled
trials, is lacking.
This project will be conducted as a
partnership between NIOSH and Toyota
Motors Engineering & Manufacturing
North America, Inc. (TEMA), with the
intervention evaluation study taking
place at the Toyota Motor
Manufacturing Kentucky, Inc. (TMMK)
manufacturing facility in Georgetown,
Kentucky. The prospective intervention
evaluation study will be conducted
using a group-randomized controlled
trial multi-time series design. Four
groups of 25–30 employees will be
established to test the two intervention
treatment conditions (tool support,
exercise program), a combined
intervention treatment condition, and a
control condition. The four groups will
be comprised of employees working on
two vehicle assembly lines in different
parts of the facility, on two work shifts
(first and second shift). Individual
randomization to treatment condition is
not feasible, so a group-randomization
(by work unit) will be used to assign the
four groups to treatment and control
conditions. Observations will be made
over the 10-month study period and
questionnaires will include the
Shoulder Rating Questionnaire (SRQ),
Disabilities of the Arm, Shoulder and
Hand (DASH) questionnaire, a
Standardized Nordic Questionnaire for
body part discomfort, and a Work
Organization Questionnaire. In addition
to the questionnaires a shoulder-specific
functional capacity evaluation test
battery will be administered at 90 and
210 days, immediately pre- and postintervention, to confirm the efficacy of
the targeted exercise program in
improving shoulder capacity.
E:\FR\FM\11JYN1.SGM
11JYN1
40890
Federal Register / Vol. 77, No. 133 / Wednesday, July 11, 2012 / Notices
In summary, this study will evaluate
the effectiveness of two interventions to
reduce musculoskeletal symptoms and
pain in the shoulder associated with
repetitive overhead work in the
manufacturing industry and will
disseminate the results of evidencebased prevention practices to the
greatest audience possible. NIOSH
expects to complete data collection in
2014.
There are no costs to respondents
other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
PAR–Q (Physical Activity Readiness) .............................................................
Shoulder Rating Questionnaire (SRQ) ............................................................
Disabilities of the Arm Shoulder and Hand (DASH) ........................................
Standardized Nordic Questionnaire for Musculoskeletal Symptoms Instrument .............................................................................................................
Work Org Questionnaire ..................................................................................
125
125
125
1
10
10
2/60
4/60
6/60
4
83
125
125
125
10
3
4/60
26/60
83
163
Total ..........................................................................................................
........................
........................
........................
458
Kimberly S. Lane,
Deputy Director, Office of Science Integrity,
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2012–16911 Filed 7–10–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
srobinson on DSK4SPTVN1PROD with NOTICES
Subcommittee on Procedures Review,
Advisory Board on Radiation and
Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
Time and Date:
9 a.m.–5 p.m., Eastern Time, July 31,
2012
Place: Cincinnati Airport Marriott,
2395 Progress Drive, Hebron, Kentucky
41018, Telephone: (859) 334–4611, Fax:
(859) 334–4619.
Status: Open to the public, but
without an oral public comment period.
To access by conference call dial the
following information: 1 (866) 659–
0537, Participant Pass Code 9933701.
Background: The ABRWH was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
compensation program. Key functions of
the ABRWH include providing advice
VerDate Mar<15>2010
18:11 Jul 10, 2012
Jkt 226001
on the development of probability of
causation guidelines that have been
promulgated by the Department of
Health and Human Services (HHS) as a
final rule; advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule;
advice on the scientific validity and
quality of dose estimation and
reconstruction efforts being performed
for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special
Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the ABRWH to
HHS, which subsequently delegated this
authority to CDC. NIOSH implements
this responsibility for CDC. The charter
was issued on August 3, 2001, renewed
at appropriate intervals, and will expire
on August 3, 2013.
Purpose: The ABRWH is charged with
(a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b)
providing advice to the Secretary, HHS,
on the scientific validity and quality of
dose reconstruction efforts performed
for this program; and (c) upon request
by the Secretary, HHS, advising the
Secretary on whether there is a class of
employees at any Department of Energy
facility who were exposed to radiation
but for whom it is not feasible to
estimate their radiation dose, and on
whether there is a reasonable likelihood
that such radiation doses may have
endangered the health of members of
this class. The Subcommittee on
Procedures Review was established to
aid the ABRWH in carrying out its duty
to advise the Secretary, HHS, on dose
reconstructions. The Subcommittee on
Procedures Review is responsible for
overseeing, tracking, and participating
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
in the reviews of all procedures used in
the dose reconstruction process by the
NIOSH Division of Compensation
Analysis and Support (DCAS) and its
dose reconstruction contractor.
Matters To Be Discussed: The agenda
for the Subcommittee meeting includes
discussion of the following Oak Ridge
Associated Universities and DCAS
procedures: DCAS TIB–0013 (‘‘Selected
Geometric Exposure Scenario
Considerations for External Dose
Reconstruction at Uranium Facilities’’),
OTIB–0052 (‘‘Parameters to Consider
When Processing Claims for
Construction Trade Workers’’), OTIB–
0054 (‘‘Fission and Activation Product
Assignment for Internal Dose-Related
Gross Beta and Gross Gamma
Analyses’’), PER 14 (‘‘Construction
Trades Workers’’), PER 17 (Evaluation of
Incomplete internal Dosimetry records
from Idaho, Argonne-East and ArgonneWest National Laboratories’’), and PER
20 (‘‘Blockson TBD Revision’’);
Identification of Overarching Dose
Reconstruction Issues; Discussion of
New Summaries of Completed
Procedure Reviews; and a continuation
of the comment-resolution process for
other dose reconstruction procedures
under review by the Subcommittee.
The agenda is subject to change as
priorities dictate.
This meeting is open to the public,
but without an oral public comment
period. In the event an individual
wishes to provide comments, written
comments may be submitted. Any
written comments received will be
provided at the meeting and should be
submitted to the contact person below
in advance of the meeting.
Contact Person for More Information:
Theodore Katz, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton
Road, Mailstop E–20, Atlanta, Georgia
E:\FR\FM\11JYN1.SGM
11JYN1
Agencies
[Federal Register Volume 77, Number 133 (Wednesday, July 11, 2012)]
[Notices]
[Pages 40889-40890]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-16911]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-12-12PE]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570
and send comments to Kimberly S. Lane, at CDC 1600 Clifton Road, MS-
D74, Atlanta, GA 30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Interventions to Reduce Shoulder MSDs in Overhead Assembly--New -
National Institute for Occupational Safety and Health (NIOSH), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
The mission of the National Institute for Occupational Safety and
Health (NIOSH) is to promote safety and health at work for all people
through research and prevention. Under Public Law 91- 596, sections 20
and 22 (Section 20-22, Occupational Safety and Health Act of 1970),
NIOSH has the responsibility to conduct research to advance the health
and safety of workers. In this capacity, NIOSH proposes to conduct a
study to assess the effectiveness and cost-benefit of occupational
safety and health (OSH) interventions to prevent musculoskeletal
disorders (MSDs) among workers in the Manufacturing (MNF) sector.
Musculoskeletal disorders (MSDs) represent a major proportion of
injury/illness incidence and cost in the U.S. Manufacturing (MNF)
sector. In 2008, 29% of non-fatal injuries and illnesses involving days
away from work (DAW) in the MNF sector involved MSDs and the MNF sector
had some of the highest rates of MSD DAW cases. The rate for the motor
vehicle manufacturing sub-sector (NAICS 3361) was among the highest of
MNF sub sectors, with MSD DAW rates that were higher than the general
manufacturing MSD DAW rates from 2003-2007. In automotive
manufacturing, overhead conveyance of the vehicle chassis requires
assembly line employees to use tools in working postures with the arms
elevated. These postures are believed to be associated with symptoms of
upper limb discomfort, fatigue, and impingement syndromes (Fischer et
al., 2007). Overhead working posture, independent of the force or load
exerted with the hands, may play a role in the development in these
conditions. However, recent studies suggest a more significant role of
localized shoulder muscle fatigue in contributing to these disorders.
Fatigue of the shoulder muscles may result in changes in normal
shoulder kinematics (motion) that affect risk for shoulder impingement
disorders (Ebaugh et. al., 2006; Chopp et al., 2010).
The U.S. Manufacturing sector has faced a number of challenges
including an overall decline in jobs, an aging workforce, and changes
in organizational management systems. Studies have indicated that the
average age of industrial workers is increasing and that older workers
may differ from younger workers in work capacity, injury risk, severity
of injuries, and speed of recovery (Kenny et al., 2008; Gall et al.,
2004; Restrepo et al., 2006). As the average age of the industrial
population increases and newer systems of work organization (such as
lean manufacturing) are changing the nature of labor-intensive work,
prevention of MSDs will be more critical to protecting older workers
and maintaining productivity.
This study will evaluate the efficacy of two intervention
strategies for reducing musculoskeletal symptoms and pain in the
shoulder attributable to overhead assembly work in automotive
manufacturing. These interventions are, (1) an articulating spring-
tensioned tool support device that unloads from the worker the weight
of the tool that would otherwise be manually supported, and, (2) a
targeted exercise program intended to increase individual employees'
strength and endurance in the shoulder and upper arm stabilizing muscle
group. As a primary prevention strategy, the tool support engineering
control approach is preferred; however, a cost-efficient opportunity
exists to concurrently evaluate the efficacy of a preventive exercise
program intervention. Both of these intervention approaches have been
used in the Manufacturing sector, and preliminary evidence suggests
that both approaches may have merit. However, high quality evidence
demonstrating their effectiveness, by way of controlled trials, is
lacking.
This project will be conducted as a partnership between NIOSH and
Toyota Motors Engineering & Manufacturing North America, Inc. (TEMA),
with the intervention evaluation study taking place at the Toyota Motor
Manufacturing Kentucky, Inc. (TMMK) manufacturing facility in
Georgetown, Kentucky. The prospective intervention evaluation study
will be conducted using a group-randomized controlled trial multi-time
series design. Four groups of 25-30 employees will be established to
test the two intervention treatment conditions (tool support, exercise
program), a combined intervention treatment condition, and a control
condition. The four groups will be comprised of employees working on
two vehicle assembly lines in different parts of the facility, on two
work shifts (first and second shift). Individual randomization to
treatment condition is not feasible, so a group-randomization (by work
unit) will be used to assign the four groups to treatment and control
conditions. Observations will be made over the 10-month study period
and questionnaires will include the Shoulder Rating Questionnaire
(SRQ), Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire,
a Standardized Nordic Questionnaire for body part discomfort, and a
Work Organization Questionnaire. In addition to the questionnaires a
shoulder-specific functional capacity evaluation test battery will be
administered at 90 and 210 days, immediately pre- and post-
intervention, to confirm the efficacy of the targeted exercise program
in improving shoulder capacity.
[[Page 40890]]
In summary, this study will evaluate the effectiveness of two
interventions to reduce musculoskeletal symptoms and pain in the
shoulder associated with repetitive overhead work in the manufacturing
industry and will disseminate the results of evidence-based prevention
practices to the greatest audience possible. NIOSH expects to complete
data collection in 2014.
There are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondents Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
PAR-Q (Physical Activity Readiness)............. 125 1 2/60 4
Shoulder Rating Questionnaire (SRQ)............. 125 10 4/60 83
Disabilities of the Arm Shoulder and Hand (DASH) 125 10 6/60 125
Standardized Nordic Questionnaire for 125 10 4/60 83
Musculoskeletal Symptoms Instrument............
Work Org Questionnaire.......................... 125 3 26/60 163
---------------------------------------------------------------
Total....................................... .............. .............. .............. 458
----------------------------------------------------------------------------------------------------------------
Kimberly S. Lane,
Deputy Director, Office of Science Integrity, Office of the Associate
Director for Science, Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2012-16911 Filed 7-10-12; 8:45 am]
BILLING CODE 4163-18-P